Pharmafile Logo
Pharmafocus logo
Advanced Search

Tresiba

Showing 12 posts of 12 posts found.

novo_flag

Novo’s Tresiba lowers hypoglycaemia risk compared to insulin glargine in type 2 diabetes

September 20, 2019
Medical Communications, Research and Development Novo Nordisk, Tresiba, diabetes, pharma

Novo Nordisk has unveiled new data for Tresiba (insulin degludec) at the 55th Annual Meeting of the European Association for …

News
novo_flag

Novo Nordisk unveils hard-hitting data for two of its diabetes therapies

December 5, 2017
Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …

News
novo_flag

Novo Nordisk presents Tresiba data showing significantly lower hypoglycaemia rates

June 13, 2016
Research and Development, Sales and Marketing Novo Nordisk, Tresiba

Novo Nordisk (CPH: NOVO-B) has presented new Phase IIIb data on Tresiba (insulin degludec) at the American Diabetes Association annual …

News
novo_flag

FDA committee unanimously recommends Novo Nordisk diabetes combo, IDegLira

May 25, 2016
Research and Development, Sales and Marketing FDA, Novo Nordisk, Panel, Tresiba, Victoza, committee, ideglira, recommendation, staff

Novo Nordisk has announced that a US Food and Drug Administration (FDA) advisory committee has unanimously recommended IDegLira, a type-2 …

News
Novo Nordisk building

FDA approves Novo Nordisk’s diabetes drugs

September 28, 2015
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin

The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …

News

Novo Nordisk pulls Tresiba in Germany after pricing row

July 6, 2015
Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access

Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …

News
Novo image

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …

News
Novo image

Novo resubmits FDA application for two diabetes drugs

March 27, 2015
Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes

Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …

News

Novo Nordisk to open $130 million diabetes labs

November 3, 2014
Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes

Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …

News
Novo Nordisk image

FDA rejects Novo diabetes drugs

February 12, 2013
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba

The FDA has knocked back two of Novo Nordisk’s diabetes drugs – just weeks after they were approved for use …

News
Novo Nordisk image

EU approval for Novo Nordisk diabetes drugs

January 24, 2013
Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba

Novo Nordisk is celebrating after European regulators approved two of its drugs for the treatment of adults with diabetes. The …

News
Novo Nordisk image

European green light for Novo’s Tresiba

October 24, 2012
Sales and Marketing EMA, Novo Nordisk, Tresiba

The European Medicines Agency has given the go-ahead for Novo Nordisk’s Tresiba, a new basal analogue insulin to treat diabetes …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024